ANTAGONIST

European and North American populations should be screened for coeliac disease

P J Kumar

Barts and the London, Queen Mary School of Medicine and Dentistry, Turner St, London E1 2AD, UK; p.j.kumar@qmul.ac.uk

Correspondence to:
P J Kumar Barts and the London, Queen Mary School of Medicine and Dentistry, Turner St, London E1 2AD, UK;p.j.kumar@qmul.ac.uk

Accepted 4 September 2002

Keywords: coeliac disease; screening

The first 150 words of the full text of this article appear below.

As European and North American societies become more opulent, the focus of attention moves inevitably from diagnosis and treatment of diseases to screening of populations. Successful screening would require an increased detection of the disease, improvement in the health of that population, and prevention of known complications. Population screening involves testing of otherwise healthy people following an educational programme inviting them to participate with informed consent. If the uptake of this were small, the alternative would be the compulsory testing of body samples allowing little choice to the individual—an action hardly conducive to current societal sentiments!

For a screening test to be useful, it needs to be simple, cheap, have a high sensitivity and specificity, and be easy to perform on large numbers of the population. In coeliac disease the endomysial antibody test¹ is a possible screening tool. The specificity of this test is approaching 100%² and sensitivities of 86% . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Ian Forgacs
Gut 2003 52: 159. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• van Koppen, E. J., Schweizer, J. J., Csizmadia, C. G.D.S., Krom, Y., Hylkema, H. B., van Geel, A. M., Koopman, H. M., Verloove-Vanhorick, S. P., Mearin, M. L. (2009). Long-term Health and Quality-of-Life Consequences of Mass Screening for Childhood Celiac Disease: A 10-Year Follow-up Study. Pediatrics 123: e582-e588 [Abstract] [Full Text]  
• Korponay-Szabo, I. R, Szabados, K., Pusztai, J., Uhrin, K., Ludmany, E., Nemes, E., Kaukinen, K., Kapitany, A., Koskinen, L., Sipka, S., Imre, A., Maki, M. (2007). Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 335: 1244-1247 [Abstract] [Full Text]  
• Beattie, R M (2006). The changing face of coeliac disease.. Arch. Dis. Child. 91: 955-956 [Full Text]  
• Goddard, C J R, Gillett, H R (2006). Complications of coeliac disease: are all patients at risk?. Postgrad. Med. J. 82: 705-712 [Abstract] [Full Text]  
• Shamir, R., Hernell, O., Leshno, M. (2006). Cost-Effectiveness Analysis of Screening for Celiac Disease in the Adult Population. Med Decis Making 26: 282-293 [Abstract]  

eLetters:

Read all eLetters

Population based screening for coeliac disease: Patient’s choice or doctors decision

Sauid Ishaq

Gut Online, 25 Mar 2004 [Full text]